Prognostic factors in gastrointestinal endocrine tumors.
about
Transcatheter embolization therapy in liver cancer: an update of clinical evidencesNeuroendocrine tumors of the gastro-entero-pancreatic systemThe accuracy of survival time prediction for patients with glioma is improved by measuring mitotic spindle checkpoint gene expressionManagement and outcomes of patients with recurrent neuroendocrine liver metastasis after curative surgery: An international multi-institutional analysis.An elevated serum alkaline phosphatase level in hepatic metastases of grade 1 and 2 gastrointestinal neuroendocrine tumors is unusual and of prognostic value.Molecular characteristics and predictors of survival in patients with malignant neuroendocrine tumors.Prognostic value of Ki67 index in gastrointestinal stromal tumors.Multimodal management of neuroendocrine liver metastases.Diagnosis and prediction of neuroendocrine liver metastases: a protocol of six systematic reviews.Predictors of response to radio-embolization (TheraSphere®) treatment of neuroendocrine liver metastasis.Antiangiogenic and antihepatocellular carcinoma activities of the Juniperus chinensis extract.Gastroenteropancreatic Neuroendocrine Tumors with Liver Metastases in Korea: A Clinicopathological Analysis of 72 Cases in a Single InstituteInverse expression of somatostatin and CXCR4 chemokine receptors in gastroenteropancreatic neuroendocrine neoplasms of different malignancyDiscordance of Histologic Grade Between Primary and Metastatic Neuroendocrine Carcinomas.Neoadjuvant peptide receptor radionuclide therapy for an inoperable neuroendocrine pancreatic tumor.Accomplishments in 2008 in the management of gastrointestinal neuroendocrine tumors.Immunohistochemical Markers as Predictors of Histopathologic Response and Prognosis in Rectal Cancer Treated with Preoperative Adjuvant Therapy: State of the Art.Surgical treatment of liver metastases in neuroendocrine neoplasms.Pancreatic neuroendocrine and carcinoid tumors: what's new, what's old, and what's different?Liver transplantation for malignancies.Early Recurrence of Neuroendocrine Liver Metastasis After Curative Hepatectomy: Risk Factors, Prognosis, and Treatment.5th International ACC Symposium: Classification of Adrenocortical Cancers from Pathology to Integrated Genomics: Real Advances or Lost in Translation?Expression of CD24, a Stem Cell Marker, in Pancreatic and Small Intestinal Neuroendocrine Tumors.Transarterial Chemoembolization for Metastatic Neuroendocrine Tumors With Massive Hepatic Tumor Burden: Is the Benefit Worth the Risk?Subgroup analysis of patients with G2 gastroenteropancreatic neuroendocrine tumors.Neuroendocrine tumor of unknown primary accompanied with stomach adenocarcinoma.Treatment of neuroendocrine tumor liver metastases.A nation-wide retrospective epidemiological study of gastroenteropancreatic neuroendocrine neoplasms in china.Timing of disease occurrence and hepatic resection on long-term outcome of patients with neuroendocrine liver metastasis.A Novel Nomogram to Predict the Prognosis of Patients Undergoing Liver Resection for Neuroendocrine Liver Metastasis: an Analysis of the Italian Neuroendocrine Liver Metastasis Database.Neuroendocrine tumor of gallbladder with liver and retroperitoneal metastases and a good response to the chemotherapeutical treatment.PTOV1 is overexpressed in human high-grade malignant tumorsThe Long-Term Benefit of Liver Transplantation for Hepatic Metastases From Neuroendocrine Tumors
P2860
Q27003849-583BBD40-49D7-4CC6-A08D-0B590172BBA3Q28294432-E15029E7-C8DF-470F-9876-FAF4669F36E6Q28743982-3AFA045E-741D-4AE3-959F-87639A2A1B8AQ30252389-49AF7FB7-C32C-473F-BE23-648851674847Q33745867-E58F07A6-D754-4035-9E37-8BC75E635121Q33775632-9C2BF227-B6E1-46BE-ABC5-B7AF9D57BD2EQ33802994-342493BF-111B-48C0-97F7-4D526AC94918Q34528199-48FCD81B-A06F-4BEE-B7D3-5CCB99E6E947Q35074944-CD2212B4-8EB0-4B63-BEA1-82E7A99F8B8DQ35658025-1161306F-E048-4B75-A1B3-A4E8FBA6E908Q36097965-DD3B45A7-2A8A-4858-8F51-6F593EEBCBA7Q36187104-15BE3017-8645-4FED-8CA6-DA024F4198B4Q36413831-EEEC63AD-5A95-4C43-A77A-D0D2E8290AFCQ36879154-9FABC30C-3B3E-47B0-9449-610866464F35Q37468506-3655E90D-7B4A-4F34-9F90-92D22684B5D2Q37468838-DA5082BB-940E-47D4-A9E3-C5322CA69FD6Q37689910-B92D7CAA-D347-40C8-BEF0-62922D97C53CQ37982721-A5A813E7-B2FD-4E23-A0D2-471173FF6839Q37995522-4BD80F8D-D9E6-4AFB-83F6-7577F5DD4263Q38194071-80CA407B-4C17-4161-8ECD-A908722C0A8AQ38668755-C1B36F3F-B613-4056-90A1-FE6CAEAB9550Q38671542-2259EE49-BEE2-4B51-8D1B-F8137D8CC88CQ38962257-5ECCA801-EF46-46F4-9F13-0D550180FDECQ39170189-88283810-9C69-4F56-954A-B579548F54EEQ40773502-071981A8-A416-48C5-9B00-7B296C9C1389Q40894684-F4BA426E-645D-402A-858F-F364B3E44976Q42287138-DE8DE0A6-3AF8-4122-BA5F-CD1D537BA78DQ42700898-92769B3F-B9ED-473C-B6F2-AF69E6C9BC68Q45068093-C7B13324-7A04-46DF-837B-233D7D6DA77EQ48122207-24E4B8EB-4ABC-414C-84C1-690A79ED6546Q50169985-B789F519-79E5-4F7D-9F78-DC4B9098FD83Q56999360-BD5E8897-A8F0-4559-848A-87076582DD9EQ58199966-7720CEF5-7859-4AB7-A7E4-9F1414BF338C
P2860
Prognostic factors in gastrointestinal endocrine tumors.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Prognostic factors in gastrointestinal endocrine tumors.
@en
Prognostic factors in gastrointestinal endocrine tumors.
@nl
type
label
Prognostic factors in gastrointestinal endocrine tumors.
@en
Prognostic factors in gastrointestinal endocrine tumors.
@nl
prefLabel
Prognostic factors in gastrointestinal endocrine tumors.
@en
Prognostic factors in gastrointestinal endocrine tumors.
@nl
P2093
P1433
P1476
Prognostic factors in gastrointestinal endocrine tumors.
@en
P2093
Cesare Bordi
Elisabetta Froio
Giovanni Fellegara
Tiziana D'Adda
P2888
P304
P356
10.1007/S12022-007-0020-X
P50
P577
2007-01-01T00:00:00Z